Pharmaceutical Products for CDER Research Studies - IDIQ
Archived on May 30, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM CDT
- Posted
- May 11, 2026
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Oct 31, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75F40126Q132721
- Notice ID
- c1c1dfb5988b4bd8ad101adfccd93d36
Description
5/11/2026:
Questions and answers:
- Current or most recent incumbent contractor/vendor name
Response: WE Pharma, LLC
- Previous contract number and/or SAM.gov solicitation number
Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072.
- Contract award value or estimated annual spend
Response: The prior IDIQ Ceiling was $9,500,000.00.
- Historical pricing information or awarded pricing structure
Response: Historical pricing information and awarded pricing structure are not being provided as part of this solicitation Q&A. Requests for agency records on pricing may be submitted through the applicable FOIA process and will be reviewed for releasability.
- Period of performance of the incumbent contract
Response: 9/30/2020 to 9/29/2025.
- Any publicly available award documentation or reference links
Response: None that we are aware of.
5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan.
See attached combined synopsis/solicitation.
Award Overview
Contacts
Contracting Officer
Primary Contact
Documents
Files (3)
- Download
Amendment 1 Sol Doc combined synopsis-solicitation 75F40126Q132721.pdf
862 KBAdded in Combined Synopsis/Solicitation version 5Posted - Download
Sol Doc combined synopsis-solicitation 75F40126Q132721.pdf
841 KBAdded in Combined Synopsis/Solicitation version 4Posted - Download
Attachment 1 Comprehensive Drug Products list.xlsx
26 KBAdded in Combined Synopsis/Solicitation version 4Posted
Lifecycle
- 3Version 3Sources SoughtArchived
Pharmaceutical Products for CDER Research Studies - IDIQ
- 4Version 4Combined Synopsis/SolicitationArchived
Type changed from Sources Sought to Combined Synopsis/Solicitation
Pharmaceutical Products for CDER Research Studies - IDIQ
- 5Version 5Combined Synopsis/SolicitationArchived
Pharmaceutical Products for CDER Research Studies - IDIQ
- 7Version 7Combined Synopsis/SolicitationArchivedCurrent
Pharmaceutical Products for CDER Research Studies - IDIQ
- 10Version 10Award NoticeArchived
Type changed from Combined Synopsis/Solicitation to Award Notice
Pharmaceutical Products for CDER Research Studies - IDIQ
Similar Opportunities
Additional Details
Solicitation Number
75F40126Q132721
Archive Date
May 30, 2026
Office Address
Rockville, MD, 20852